The protective role of melatonin on the brain in a rat model of Alzheimer’s disease
- 1 July 2026
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 41 (1) , 151
Abstract
Alzheimer’s disease is an age-related neurodegenerative disorder characterized by progressive cognitive decline and multiple biochemical and structural abnormalities in the brain. Accumulating evidence suggests that aluminum exposure may contribute to neurodegenerative process including those observed in AD and was linked to neuronal damage and cognitive impairment. Melatonin (Mel) is a neurohormone that regulates circadian rhythm and possesses antioxidant, anti-inflammatory and neuroprotective properties. The current study investigated the potential protective roles of Mel in a rat model of AD induced by aluminum chloride (AlCl3). Forty adult male rats were divided into 4 experimental groups: a control group, an AlCl3-treated group, an AlCl3+Mel-treated group, and a Mel-only group. AlCl3 was administered orally for four weeks. Cognitive performance and spatial learning were assessed using Morris water maze test. Plasma levels of the pro inflammatory cytokines; interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) were measured using enzyme linked immunosorbent assay. Histopathological examination of the frontal cortex was performed using hematoxylin and eosin staining, and immunohistochemistry was conducted using the neuronal marker NeuN, microglial marker Iba1, and inflammatory markers IL-6 and TNF-α. Mel treatment significantly improved learning and memory performance in the Morris water maze test. It also reduced plasma levels of IL-6 and TNF-α. Using immunohistochemistry, Mel increased NeuN expression, while reducing Iba1, IL-6 and TNF-α expression. These findings showed that Mel attenuated frontal cortical neurodegeneration and neuroinflammation in this model of AD, suggesting that Mel may represent a promising neuroprotective therapeutic strategy for AD. Graphical AbstractKeywords
This publication has 46 references indexed in Scilit:
- The Association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer's DiseaseCurrent Alzheimer Research, 2021
- Phosphorylated tau interactome in the human Alzheimer’s disease brainBrain, 2020
- Angelica polysaccharide ameliorates memory impairment in Alzheimer’s disease rat through activating BDNF/TrkB/CREB pathwayExperimental Biology and Medicine, 2019
- Melatonin Rescue Oxidative Stress-Mediated Neuroinflammation/ Neurodegeneration and Memory Impairment in Scopolamine-Induced Amnesia Mice ModelJournal of Neuroimmune Pharmacology, 2018
- Serum tumour necrosis factor‐α and interleukin‐6 levels in Alzheimer's disease and mild cognitive impairmentPsychogeriatrics, 2017
- Beneficial effects of melatonin in a rat model of sporadic Alzheimer’s diseaseBiogerontology, 2014
- Impact of caffeic acid on aluminium chloride-induced dementia in ratsJournal of Pharmacy and Pharmacology, 2013
- Alzheimer’s disease: pathological mechanisms and the beneficial role of melatoninJournal of Pineal Research, 2011
- Beneficial effects of melatonin in experimental models of Alzheimer disease1Acta Pharmacologica Sinica, 2006
- Effects of aluminum on the nervous system and its possible link with neurodegenerative diseasesJournal of Alzheimer’s Disease, 2005